Quarterly report [Sections 13 or 15(d)]

Condensed Consolidated Balance Sheets (Parenthetical)

v3.25.3
Condensed Consolidated Balance Sheets (Parenthetical) - USD ($)
$ in Millions
Sep. 30, 2025
Dec. 31, 2024
Allowance for credit losses $ 74 $ 91
Accumulated depreciation 993 958
Current portion of debt, fair value $ 82 $ 282
Series A common stock    
Common stock, par value (in dollars per share) $ 0.01 $ 0.01
Common stock, shares authorized (in shares) 4,000,000,000 4,000,000,000
Common stock, shares issued (in shares) 7,886,235 7,793,090
Common stock, shares outstanding (in shares) 7,886,235 7,793,090
Series B common stock    
Common stock, par value (in dollars per share) $ 0.01 $ 0.01
Common stock, shares authorized (in shares) 150,000,000 150,000,000
Common stock, shares issued (in shares) 182,233 178,557
Common stock, shares outstanding (in shares) 182,233 178,557
Series C common stock    
Common stock, par value (in dollars per share) $ 0.01 $ 0.01
Common stock, shares authorized (in shares) 4,000,000,000 4,000,000,000
Common stock, shares issued (in shares) 0 0